aCenters for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB); and

bCenters for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), HIV Surveillance Branch (HSB).

Correspondence to: Alex Viguerie, PhD, Centers for Disease Control and Prevention, Division of HIV Prevention, Quantitative Sciences Branch, 12 Corporate Square Boulevard, Atlanta, GA 30329 (e-mail: [email protected]).

This work was supported by the Centers for Disease Control and Prevention.

The authors have no conflicts of interest to disclose.

The data used for this analysis were collected as part of the public health program activity called PS18-1802 Integrated HIV Surveillance and Prevention Programs for Health Departments (Component A), which is a routine disease surveillance activity across 60 jurisdictions throughout the United States. A project determination made by the National Center for HIV, Hepatitis, STD, and TB Prevention (NCHHSTP) on behalf of the Centers for Disease Control and Prevention (CDC) on January 22, 2018, determined this project to be exempt from needing IRB review as it is not human subjects research. The National Center for HIV, Hepatitis, STD, and TB Prevention (NCHHSTP) on behalf of the Centers for Disease Control and Prevention (CDC) approved the use of these data in the current document on August 25, 2022.

The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).